Macroview Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24
| Closed | -$1.61K | – | 219 |
|
|
2024
Q3 | $1.61K | Hold |
24
| – | – | ﹤0.01% | 499 |
|
|
2024
Q2 | $2.72K | Hold |
24
| – | – | ﹤0.01% | 458 |
|
|
2024
Q1 | $3.33K | Sell |
24
-62
| -72% | -$7.79K | ﹤0.01% | 458 |
|
|
2023
Q4 | $10.7K | Buy |
86
+42
| +95% | +$4.29K | 0.01% | 246 |
|
|
2023
Q3 | $4.11K | Buy |
44
+40
| +1,000% | +$4.51K | 0.01% | 473 |
|
|
2023
Q2 | $515 | Hold |
4
| – | – | ﹤0.01% | 449 |
|
|
2023
Q1 | $465 | Hold |
4
| – | – | ﹤0.01% | 412 |
|
|
2022
Q4 | $453 | Hold |
4
| – | – | ﹤0.01% | 421 |
|
|
2022
Q3 | $0 | Sell |
4
-4
| -50% | -$339 | ﹤0.01% | 437 |
|
|
2022
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 392 |
|
|
2022
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 376 |
|
|
2021
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 345 |
|
|
2021
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 338 |
|
|
2021
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 363 |
|
|
2021
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 339 |
|
|
2020
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 314 |
|
|
2020
Q3 | $1K | Buy |
+8
| New | +$836 | ﹤0.01% | 288 |
|
|
2020
Q1 | – | Sell |
-68
| Closed | -$4K | – | 313 |
|
|
2019
Q4 | $4K | Buy |
+68
| New | +$3.23K | 0.01% | 186 |
|
|
2019
Q2 | – | Sell |
-88
| Closed | -$3K | – | 317 |
|
|
2019
Q1 | $3K | Sell |
88
-8
| -8% | -$281 | 0.01% | 235 |
|
|
2018
Q4 | $3K | Buy |
+96
| New | +$3.04K | 0.01% | 194 |
|
|
2018
Q3 | – | Sell |
-136
| Closed | -$3K | – | 331 |
|
|
2018
Q2 | $3K | Buy |
+136
| New | +$2.88K | 0.01% | 181 |
|
Other funds holding DXCM
N
